Summit Therapeutics SMMT Stock Is It the Right Time to Invest Q4 2025 Below Expectations CVS Health CVS Valuation Disparity and Bearish Downside Risks Amid Mixed Share Price Momentum OSBC Old Second stock rises 19 percent following Q1 2026 results even as it misses analyst consensus EPS estimates Syndax Pharmaceuticals SNDX Stock Price Movement Behavior Q4 2025 Earnings Underperform ABX Abacus Global posts Q4 2025 earnings per share 186 percent above consensus estimates as shares stay flat